[go: up one dir, main page]

NO20063619L - Diarylmetylpiperazinderivater, fremstilling og anvendelse derav - Google Patents

Diarylmetylpiperazinderivater, fremstilling og anvendelse derav

Info

Publication number
NO20063619L
NO20063619L NO20063619A NO20063619A NO20063619L NO 20063619 L NO20063619 L NO 20063619L NO 20063619 A NO20063619 A NO 20063619A NO 20063619 A NO20063619 A NO 20063619A NO 20063619 L NO20063619 L NO 20063619L
Authority
NO
Norway
Prior art keywords
diarylmethylpiperazine
derivatives
preparation
compounds
enantiomers
Prior art date
Application number
NO20063619A
Other languages
English (en)
Inventor
William L Brown
Andrew Griffin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31493012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063619(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20063619L publication Critical patent/NO20063619L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forbindelser av formel: hvor R1, R2 og R3 er som definert i beskrivelsen og i de medfølgende krav, samt salter, enantiomerer derav og farmasøytiske preparater som innbefatter forbindelsene er fremstilt. De er nyttige i terapi, spesielt i behandlingen av smerte.
NO20063619A 2004-01-09 2006-08-09 Diarylmetylpiperazinderivater, fremstilling og anvendelse derav NO20063619L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400027A SE0400027D0 (sv) 2004-01-09 2004-01-09 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
PCT/SE2005/000014 WO2005066148A1 (en) 2004-01-09 2005-01-05 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof

Publications (1)

Publication Number Publication Date
NO20063619L true NO20063619L (no) 2006-10-09

Family

ID=31493012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063619A NO20063619L (no) 2004-01-09 2006-08-09 Diarylmetylpiperazinderivater, fremstilling og anvendelse derav

Country Status (18)

Country Link
US (1) US20070293502A1 (no)
EP (1) EP1706393A1 (no)
JP (1) JP2007517873A (no)
KR (1) KR20060123446A (no)
CN (1) CN1926122A (no)
AR (1) AR047094A1 (no)
AU (1) AU2005204010A1 (no)
BR (1) BRPI0506702A (no)
CA (1) CA2552851A1 (no)
IL (1) IL176513A0 (no)
MX (1) MXPA06007664A (no)
NO (1) NO20063619L (no)
SA (1) SA05250441A (no)
SE (1) SE0400027D0 (no)
TW (1) TW200524609A (no)
UY (1) UY28715A1 (no)
WO (1) WO2005066148A1 (no)
ZA (1) ZA200605442B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4549024B2 (ja) 2001-05-18 2010-09-22 アストラゼネカ・アクチエボラーグ ４（フェニル−ピペラジニル−メチル）ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
HRP20120343T1 (hr) 2004-08-02 2012-05-31 Astrazeneca Ab Derivati diarilmetil piperazina, njihovi pripravci i njihova uporaba
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
NZ573129A (en) 2006-06-28 2011-06-30 Amgen Inc Piperazine acetic acid glycine transporter-1 inhibitors
NZ590041A (en) * 2008-05-20 2012-11-30 Astrazeneca Ab Method of treating anxious major depressive disorder
KR101516703B1 (ko) * 2013-02-20 2015-05-04 김슬기 영아 시트 침대

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583713A5 (no) * 1973-06-29 1977-01-14 Cermol Sa
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0101765D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds

Also Published As

Publication number Publication date
SE0400027D0 (sv) 2004-01-09
CN1926122A (zh) 2007-03-07
WO2005066148A1 (en) 2005-07-21
TW200524609A (en) 2005-08-01
UY28715A1 (es) 2005-08-31
CA2552851A1 (en) 2005-07-21
KR20060123446A (ko) 2006-12-01
ZA200605442B (en) 2007-04-25
US20070293502A1 (en) 2007-12-20
AU2005204010A1 (en) 2005-07-21
SA05250441A (ar) 2005-12-03
JP2007517873A (ja) 2007-07-05
MXPA06007664A (es) 2006-09-04
IL176513A0 (en) 2008-02-09
AR047094A1 (es) 2006-01-04
EP1706393A1 (en) 2006-10-04
BRPI0506702A (pt) 2007-05-02

Similar Documents

Publication Publication Date Title
SE0401971D0 (sv) Piperidne derivatives
NO20065904L (no) Terapeutiske forbindelser
TW200716628A (en) Novel compounds
SE0401970D0 (sv) Novel compounds
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20063619L (no) Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
TW200504059A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
NO20053805L (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
TW200510313A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
TW200510312A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
NO20063618L (no) Diarylmetylpiperidinderivater, fremstilling og anvendelse derav
SE0400285D0 (sv) Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
TW200500356A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
NO20063617L (no) Diarylmetylidenpiperidinderivater, fremstilling og anvendelse derav
NO20055142L (no) Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
NO20055998L (no) Diarylmetylidenpiperidinderivater, preparater derav og anvendelse derav
NO20063353L (no) 1,2,3,4-tetrahydroisokinolinderivater, fremgangsmate for fremstilling derav og anvendelser derav
TW200504018A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
TW200507842A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application